The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Prostate Cancer Genetics: Variation by Race, Ethnicity, and Geography
Open accessAbstract
Prostate cancer rates vary substantially by race, ethnicity, and geography. These disparities can be explained by variation in access to screening and treatment, variation in exposure to prostate cancer risk factors, and variation in the underlying biology of prostate carcinogenesis (including genomic propensity of some groups to develop biologically aggressive disease). It is clear that access to screening and treatment are critical influencers of prostate cancer rates, yet even among geographically diverse populations with similar access to care (e.g., low and medium income countries), African descent men have higher prostate cancer rates and poorer prognosis. To date, the proportion of prostate cancer that can be explained by environmental exposures is small, and the impact of these factors across different racial, ethnic, or geographical populations is poorly understood. In contrast, prostate cancer has one of the highest heritabilities of all major cancers. Numerous genetic susceptibility markers have been identified from family-based studies, candidate gene association studies, and genome-wide association studies. Some prostate cancer loci, including the risk loci found at chromosome 8q24, have consistent effects in all groups studied to date. However, replication of many susceptibility loci across race, ethnicity, and geography remains limited, and additional studies in certain populations (particularly in men of African descent) are needed to better understand the underlying genetic basis of prostate cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,293
Lichtenstein, P., Holm, N. V., Verkasalo, P. K., Iliadou, A., Kaprio, J., Koskenvuo, M., Pukkala, E., Skytthe, A., & Hemminki, K. (2000) · New England Journal of Medicine · doi:10.1056/nejm200007133430201 · Cited by 4,114
Linkage disequilibrium in the human genome
Reich, D. E., Cargill, M., Bolk, S., Ireland, J., Sabeti, P. C., Richter, D. J., Lavery, T., Kouyoumjian, R., Farhadian, S. F., Ward, R., et al. (2001) · Nature · doi:10.1038/35075590 · Cited by 1,774
GLOBOCAN 2008 v1.2, Cancer incidence and mortality world-wide : IARC Cancer Base No. 10
Ferlay, J. (2010) · Medical Entomology and Zoology · Cited by 1,633
Genome-wide association study of prostate cancer identifies a second risk locus at 8q24
Yeager, M., Orr, N., Hayes, R. B., Jacobs, K. B., Kraft, P., Wacholder, S., Minichiello, M. J., Fearnhead, P., Yu, K., Chatterjee, N., et al. (2007) · Nature Genetics · doi:10.1038/ng2022 · Cited by 1,122
Familial Risk and Heritability of Cancer Among Twins in Nordic Countries
Mucci, L. A., Hjelmborg, J. B., Harris, J. R., Czene, K., Havelick, D. J., Scheike, T., Graff, R. E., Holst, K., Möller, S., Unger, R. H., et al. (2016) · JAMA · doi:10.1001/jama.2015.17703 · Cited by 938
Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24
Gudmundsson, J., Sulem, P., Manolescu, A., Amundadottir, L. T., Gudbjartsson, D., Helgason, A., Rafnar, T., Bergthorsson, J. T., Agnarsson, B. A., Baker, A., et al. (2007) · Nature Genetics · doi:10.1038/ng1999 · Cited by 864
Campbell, M. C., & Tishkoff, S. A. (2008) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.9.081307.164258 · Cited by 861
Castro, E., Goh, C., Olmos, D., Saunders, E., Leongamornlert, D., Tymrakiewicz, M., Mahmud, N., Dadaev, T., Govindasami, K., Guy, M., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.43.1882 · Cited by 850
Lee, W. H., Morton, R. A., Epstein, J. I., Brooks, J. D., Campbell, P. A., Bova, G. S., Hsieh, W. S., Isaacs, W. B., & Nelson, W. G. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.24.11733 · Cited by 838
A common variant associated with prostate cancer in European and African populations
Amundadottir, L. T., Sulem, P., Gudmundsson, J., Helgason, A., Baker, A., Agnarsson, B. A., Sigurdsson, A., Benediktsdottir, K. R., Cazier, J.-B., Sainz, J., et al. (2006) · Nature Genetics · doi:10.1038/ng1808 · Cited by 787
Mendelian inheritance of familial prostate cancer.
Carter, B. S., Beaty, T. H., Steinberg, G. D., Childs, B., & Walsh, P. C. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.8.3367 · Cited by 781
Multiple regions within 8q24 independently affect risk for prostate cancer
Haiman, C. A., Patterson, N., Freedman, M. L., Myers, S. R., Pike, M. C., Waliszewska, A., Neubauer, J., Tandon, A., Schirmer, C., McDonald, G. J., et al. (2007) · Nature Genetics · doi:10.1038/ng2015 · Cited by 663
TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort
Demichelis, F., Fall, K., Perner, S., Andrén, O., Schmidt, F., Setlur, S. R., Hoshida, Y., Mosquera, J.-M., Pawitan, Y., Lee, C., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210237 · Cited by 645
Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men
Freedman, M. L., Haiman, C. A., Patterson, N., McDonald, G. J., Tandon, A., Waliszewska, A., Penney, K., Steen, R. G., Ardlie, K., John, E. M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605832103 · Cited by 612
Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array
Initiative, T. C. R. U. G. (. O. G.-O., Eeles, R. A., Bioresource, T. A. P. C., The UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons' Section of Oncology, Collaborators, T. U. P. (. T. F. C. A. T. S., The PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium, Olama, A. A. A., Benlloch, S., Saunders, E. J., Leongamornlert, D. A., et al. (2013) · Nature Genetics · doi:10.1038/ng.2560 · Cited by 542
Prostate-specific membrane antigen expression as a predictor of prostate cancer progression
Perner, S., Hofer, M. D., Kim, R., Shah, R. B., Li, H., Möller, P., Hautmann, R. E., Gschwend, J. E., Kuefer, R., & Rubin, M. A. (2007) · Human Pathology · doi:10.1016/j.humpath.2006.11.012 · Cited by 455
Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer
Attard, G., Clark, J., Ambroisine, L., Fisher, G., Kovacs, G., Flohr, P., Berney, D., Foster, C. S., Fletcher, A., Gerald, W. L., et al. (2008) · Oncogene · doi:10.1038/sj.onc.1210640 · Cited by 438
TMPRSS2-ERG Fusion Prostate Cancer: An Early Molecular Event Associated With Invasion
Perner, S., Mosquera, J.-M., Demichelis, F., Hofer, M. D., Paris, P. L., Simko, J., Collins, C., Bismar, T. A., Chinnaiyan, A. M., De Marzo, A. M., et al. (2007) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000213424.38503.aa · Cited by 426
Ahmadiyeh, N., Pomerantz, M. M., Grisanzio, C., Herman, P., Jia, L., Almendro, V., He, H. H., Brown, M., Liu, X. S., Davis, M., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910668107 · Cited by 336
Pettersson, A., Graff, R. E., Bauer, S. R., Pitt, M. J., Lis, R. T., Stack, E. C., Martin, N. E., Kunz, L., Penney, K. L., Ligon, A. H., et al. (2012) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-0042 · Cited by 319
Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study
The UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons' Section of Oncology, Kote-Jarai, Z., The UK ProtecT Study Collaborators, T. A. P. C. B., The PRACTICAL Consortium, Olama, A. A. A., Giles, G. G., Severi, G., Schleutker, J., Weischer, M., Campa, D., et al. (2011) · Nature Genetics · doi:10.1038/ng.882 · Cited by 289
Association of a novel long non‐coding RNA in 8q24 with prostate cancer susceptibility
Chung, S., Nakagawa, H., Uemura, M., Piao, L., Ashikawa, K., Hosono, N., Takata, R., Akamatsu, S., Kawaguchi, T., Morizono, T., et al. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2010.01737.x · Cited by 286
Magi‐Galluzzi, C., Tsusuki, T., Elson, P., Simmerman, K., LaFargue, C., Esgueva, R., Klein, E., Rubin, M. A., & Zhou, M. (2011) · The Prostate · doi:10.1002/pros.21265 · Cited by 275
Cheng, H. H., Pritchard, C. C., Boyd, T., Nelson, P. S., & Montgomery, B. (2016) · European Urology · doi:10.1016/j.eururo.2015.11.022 · Cited by 261
Evidence for a Prostate Cancer–Susceptibility Locus on Chromosome 20
Berry, R., Schroeder, J. J., French, A. J., McDonnell, S. K., Peterson, B. J., Cunningham, J. M., Thibodeau, S. N., & Schaid, D. J. (2000) · The American Journal of Human Genetics · doi:10.1086/302994 · Cited by 253
The Heritability of Prostate Cancer in the Nordic Twin Study of Cancer
Hjelmborg, J. B., Scheike, T., Holst, K., Skytthe, A., Penney, K. L., Graff, R. E., Pukkala, E., Christensen, K., Adami, H.-O., Holm, N. V., et al. (2014) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-0568 · Cited by 252
Wandel, C. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.108506 · Cited by 246
Haiman, C. A., Chen, G. K., Blot, W. J., Strom, S. S., Berndt, S. I., Kittles, R. A., Rybicki, B. A., Isaacs, W. B., Ingles, S. A., Stanford, J. L., et al. (2011) · Nature Genetics · doi:10.1038/ng.839 · Cited by 222
Self-citationProstate Cancer Susceptibility Locus on Chromosome 1q: a Confirmatory Study
Cooney, K. A., Huang, L., Sandler, H. M., Lange, E., Lange, K., Miesfeldt, S., McCarthy, J. D., Montie, J. E., & Oesterling, J. E. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.13.955 · Cited by 202
International Consortium for Prostate Cancer Genetics, Xu, J., Lange, E. M., Lu, L., Zheng, S. L., Wang, Z., Thibodeau, S. N., Cannon-Albright, L. A., Teerlink, C. C., Camp, N. J., et al. (2013) · Human Genetics · doi:10.1007/s00439-012-1229-4 · Cited by 201
Methodological challenges of genome-wide association analysis in Africa
Teo, Y.-Y., Small, K. S., & Kwiatkowski, D. P. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2731 · Cited by 195
Li, R., Wheeler, T., Dai, H., Frolov, A., Thompson, T., & Ayala, G. (2004) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200407000-00013 · Cited by 186
Long-range interaction and correlation between MYC enhancer and oncogenic long noncoding RNA CARLo-5
Kim, T., Cui, R., Jeon, Y.-J., Lee, J.-H., Lee, J. H., Sim, H., Park, J. K., Fadda, P., Tili, E., Nakanishi, H., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1400350111 · Cited by 186
A prospective investigation of PTEN loss and ERG expression in lethal prostate cancer
Ahearn, T. U., Pettersson, A., Ebot, E. M., Gerke, T., Graff, R. E., Morais, C. L., Hicks, J. L., Wilson, K. M., Rider, J. R., Sesso, H. D., et al. (2015) · Journal of the National Cancer Institute · doi:10.1093/jnci/djv346 · Cited by 186
New approaches to disease mapping in admixed populations
Seldin, M. F., Pasaniuc, B., & Price, A. L. (2011) · Nature Reviews Genetics · doi:10.1038/nrg3002 · Cited by 172
Evidence for Molecular Differences in Prostate Cancer between African American and Caucasian Men
Khani, F., Mosquera, J. M., Park, K., Blattner, M., O'Reilly, C., MacDonald, T. Y., Chen, Z., Srivastava, A., Tewari, A. K., Barbieri, C. E., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2265 · Cited by 164
Yamoah, K., Johnson, M. H., Choeurng, V., Faisal, F. A., Yousefi, K., Haddad, Z., Ross, A. E., Alshalafa, M., Den, R. B., Lal, P., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.8912 · Cited by 152
Self-citationCharacterizing Genetic Risk at Known Prostate Cancer Susceptibility Loci in African Americans
Haiman, C. A., Chen, G. K., Blot, W. J., Strom, S. S., Berndt, S. I., Kittles, R. A., Rybicki, B. A., Isaacs, W. B., Ingles, S. A., Stanford, J. L., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1001387 · Cited by 147
for The Trans-Atlantic Prostate Group, Berney, D. M., Gopalan, A., Kudahetti, S. C., Fisher, G., Ambroisine, L., Foster, C. S., Reuter, V., Eastham, J. A., Møller, H., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604951 · Cited by 135
Prostate Cancer Susceptibility in Men of African Ancestry at 8q24
Han, Y., Rand, K. A., Hazelett, D. J., Ingles, S. A., Kittles, R. A., Strom, S. S., Rybicki, B. A., Nemesure, B. B., Isaacs, W. B., Stanford, J. L., et al. (2016) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv431 · Cited by 134
The causes of cancer in France
Boffetta, P., Tubiana, M., Hill, C., Boniol, M., Aurengo, A., Masse, R. S., Valleron, A., Monier, R., de Thé, G., Boyle, P., et al. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn597 · Cited by 119
Waters, K. M., Le Marchand, L., Kolonel, L. N., Monroe, K. R., Stram, D. O., Henderson, B. E., & Haiman, C. A. (2009) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-1142 · Cited by 116
Fine, S. W., Gopalan, A., Leversha, M. A., Al‐Ahmadie, H. A., Tickoo, S. K., Zhou, Q. C., Satagopan, J. M., Scardino, P. T., Gerald, W. L., & Reuter, V. E. (2010) · Modern Pathology · doi:10.1038/modpathol.2010.120 · Cited by 103
Validation of Genome-Wide Prostate Cancer Associations in Men of African Descent
Chang, B., Spangler, E., Gallagher, S. M., Haiman, C. A., Henderson, B. E., Isaacs, W. B., Benford, M. L., Kidd, L. R., Cooney, K. A., Strom, S. S., et al. (2011) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-0698 · Cited by 102
Self-citationTwo susceptibility loci identified for prostate cancer aggressiveness
Berndt, S. I., Wang, Z., Yeager, M., Alavanja, M. C. R., Albanes, D., Amundadottir, L. T., Andriole, G. L., Freeman, L. B., Campa, D., Cancel‐Tassin, G., et al. (2015) · Nature Communications · doi:10.1038/ncomms7889 · Cited by 101
A genome-wide association study of prostate cancer in West African men
Cook, M. B., Wang, Z., Yeboah, E. D., Tettey, Y., Biritwum, R. B., Adjei, A. A., Tay, E., Truelove, A. L., Niwa, S., Chung, C. C., et al. (2013) · Human Genetics · doi:10.1007/s00439-013-1387-z · Cited by 95
Confirmation of the HOXB13 G84E Germline Mutation in Familial Prostate Cancer
Breyer, J. P., Avritt, T. G., McReynolds, K. M., Dupont, W. D., & Smith, J. R. (2012) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-0495 · Cited by 90
Modification of the Association Between Obesity and Lethal Prostate Cancer by TMPRSS2:ERG
Pettersson, A., Lis, R. T., Meisner, A., Flavin, R., Stack, E. C., Fiorentino, M., Finn, S. P., Graff, R. E., Penney, K. L., Rider, J. R., et al. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt332 · Cited by 89
How common is familial cancer?
Hemminki, K., Sundquist, J., & Bermejo, J. L. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm414 · Cited by 80
Dietary lycopene intake and risk of prostate cancer defined by ERG protein expression
Graff, R. E., Pettersson, A., Lis, R. T., Ahearn, T. U., Markt, S. C., Wilson, K. M., Rider, J. R., Fiorentino, M., Finn, S. P., Kenfield, S. A., et al. (2016) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.115.118703 · Cited by 78
Prostate Cancer Susceptibility Locus HPC1 in Utah High-Risk Pedigrees
Neuhausen, S. L., Farnham, J. M., Kort, E. N., Tavtigian, S. V., Skolnick, M. H., & Cannon‐Albright, L. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.13.2437 · Cited by 72
Replication of prostate cancer risk loci on 8q24, 11q13, 17q12, 19q33, and Xp11 in African Americans
Hooker, S. E., Hernandez, W., Chen, H., Robbins, C. M., Torres, J. B., Ahaghotu, C. A., Carpten, J. D., & Kittles, R. A. (2009) · The Prostate · doi:10.1002/pros.21061 · Cited by 72
Hsing, A. W., Yeboah, E. D., Biritwum, R. B., Tettey, Y., Marzo, A. M. D., Adjei, A. A., Netto, G. J., Yu, K. F., Li, Y., Chokkalingam, A. P., et al. (2014) · The Journal of Urology · doi:10.1016/j.juro.2014.04.017 · Cited by 68
Prostate Cancer Risk Associated Loci in African Americans
Xu, J., Kibel, A. S., Hu, J. J., Turner, A. R., Pruett, K., Zheng, S. L., Sun, J., Isaacs, S. D., Wiley, K. E., Kim, S., et al. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0091 · Cited by 63
Generalizability of established prostate cancer risk variants in men of A frican ancestry
Han, Y., Signorello, L. B., Strom, S. S., Kittles, R. A., Rybicki, B. A., Stanford, J. L., Goodman, P. J., Berndt, S. I., Carpten, J. D., Casey, G., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.29066 · Cited by 59
Self-citationKraja, A. T., Hunt, S. C., Rao, D. C., Dávila‐Román, V. G., Arnett, D. K., & Province, M. A. (2010) · Current Hypertension Reports · doi:10.1007/s11906-010-0174-7 · Cited by 54
Ishak, M. B., & Giri, V. N. (2011) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0312 · Cited by 50
Genetic Susceptibility Loci, Pesticide Exposure and Prostate Cancer Risk
Koutros, S., Berndt, S. I., Barry, K. H., Andreotti, G., Hoppin, J. A., Sandler, D. P., Yeager, M., Burdett, L. A., Yuenger, J., Alavanja, M. C. R., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058195 · Cited by 47
Barrdahl, M., Canzian, F., Joshi, A. D., Travis, R. C., Chang-Claude, J. C., Auer, P. L., Gapstur, S. M., Gaudet, M. M., Diver, W. R., Henderson, B. E., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu223 · Cited by 42
Genomewide linkage analysis of familial prostate cancer in the Japanese population
Matsui, H., Suzuki, K., Ohtake, N., Nakata, S., Takeuchi, T., Yamanaka, H., & Inoue, I. (2003) · Journal of Human Genetics · doi:10.1007/s10038-003-0099-y · Cited by 39
Lose, F. A., Batra, J., O’Mara, T. A., et al. (2011) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2011.05.011 · Cited by 36
Knipe, D. W., Evans, D. M., Kemp, J. P., Eeles, R. A., Easton, D. F., Kote‐Jarai, Z., Olama, A. A. A., Benlloch, S., Donovan, J., Hamdy, F. C., et al. (2014) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-0889 · Cited by 34
Genome-Wide Association Scan for Variants Associated with Early-Onset Prostate Cancer
Lange, E. M., Johnson, A., Wang, Y., Zuhlke, K. A., Lu, Y., Ribado, J. V., Keele, G. R., Li, J., Duan, Q., Li, G., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093436 · Cited by 33
A comprehensive resequence‐analysis of 250 kb region of 8q24.21 in men of African ancestry
Chung, C. C., Hsing, A. W., Yeboah, E. D., Biritwum, R. B., Tettey, Y., Adjei, A. A., Cook, M. B., Marzo, A. D., Netto, G. J., Tay, E., et al. (2014) · The Prostate · doi:10.1002/pros.22726 · Cited by 28
Netto, G. J. (2013) · Advances in Anatomic Pathology · doi:10.1097/pap.0b013e3182863f80 · Cited by 27
SNPs associated with prostate cancer risk and prognosis
Susan, L. N. (2007) · Frontiers in bioscience · doi:10.2741/2375 · Cited by 20
(ToPCaP), F. T. T. P. C. P., Graff, R. E., Meisner, A., Ahearn, T. U., Fiorentino, M., Loda, M. F., Giovannucci, E. L., Mucci, L. A., & Pettersson, A. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.61 · Cited by 20
Freedland, S. J., & Aronson, W. J. (2017) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2017.05.011 · Cited by 20
Erho, N., Buerki, C., Triche, T. J., Davicioni, E., & Vergara, I. A. (2012) · Journal of Oncology · doi:10.1155/2012/541353 · Cited by 17
Neslund-Dudas, C., Levin, A., Beebe-Dimmer, J., Bock, C., Nock, N., Rundle, A. G., Jankowski, M., Krajenta, R., Dou, P. Q., Mitra, B., et al. (2014) · Cancer Causes and Control · doi:10.1007/s10552-014-0387-1 · Cited by 12
Self-citation
Cited by
Cancer health disparities in racial/ethnic minorities in the United States
Zavala, V. A., Bracci, P. M., Carethers, J. M., Carvajal-Carmona, L., Coggins, N. B., Cruz-Correa, M. R., Davis, M., de Smith, A. J., Dutil, J., Figueiredo, J. C., et al. (2021) · British Journal of Cancer · doi:10.1038/s41416-020-01038-6 · Cited by 912
Metadata
- Authors
- Rebbeck, T. R.
- Venue
- Seminars in Radiation Oncology
- Publisher
- Elsevier BV
- Published
- 2017-01
- Volume
- 27
- Issue
- 1
- Pages
- 3-10
- ISSN
- 1053-4296 (ISSN-L)
- OpenAlex
- W2516564099
- Cited by
- 329
- References
- 71
- FWCI
- 10.33
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.